|
Code
|
47312
|
|
MA number
|
EU/1/07/434/001
|
|
Product Form:
|
aer nau 1x30 dávok/825 µg (fľ.skl.jantár.)
|
|
MA Status:
|
E - Valid centralised marketing authorisation
|
|
Type of procedure:
|
EU
|
|
MAH, country:
|
GlaxoSmithKline Trading Services Limited, Ireland
|
|
Therapeutic Class:
|
69 - OTORHINOLARYNGOLOGICA
|
|
ATC:
|
| R |
RESPIRATORY SYSTEM |
| R01 |
NASAL PREPARATIONS |
| R01A |
DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE |
| R01AD |
Corticosteroids |
| R01AD12 |
Fluticasone furoate |
|
|
Shelf life:
|
36 |
|
Container:
|
glass bottle with pump and nasal applicator
|
|
Route of admin.:
|
Nasal use
|
European Medicines Agency's database
